Senior insider sale
Sr VP, Quality, GMP Oper. & IT at SUPERNUS PHARMACEUTICALS, INC. — senior position signals high conviction
$623.1K
14K shares
What this filing means
MOTTOLA FRANK plans to sell 14K shares of SUPERNUS PHARMACEUTICALS, INC. valued at approximately $623.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/25/2025ACC: 0001950047-25-006329
Officer· Sr VP, Quality, GMP Oper. & IT
Since Feb 2020
14K
Shares to sell
$623.1K
Approx. market value
14K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
8/25/2025
14KTotal acquired14K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/25/2025 | Exercise of options under a registered plan Cash | 14K | — |
| Total | 14K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
14K
Market value
$623.1K
8/25/2025
Total
Units
14K
Value
$623.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/25/2025 | 14K | $623.1K | NASDAQ | Planned |
| Total | 14K | $623.1K | ||